Table 2 Kinetic characterization of selected Ssal-KRED variants using ketone 1a for the synthesis of 2a
From: Effective engineering of a ketoreductase for the biocatalytic synthesis of an ipatasertib precursor
Ssal-KRED variant | app. KM, [µM] | app. kcat, [min−1] | app. kcat/KM, [min−1 mM−1] | rel. kcat |
---|---|---|---|---|
WT | 11.9 ± 1.1 | 0.49 ± 0.02 | 41 | 1 |
M1 | 162.8 ± 7.8 | 5.8 ± 0.1 | 35.5 | 12 |
M2 | 175.2 ± 9.9 | 6.2 ± 0.2 | 35.6 | 13 |
M3 | 299.7 ± 7.9 | 15.3 ± 0.4 | 51.2 | 31 |
M4a | 1668 ± 103 | 45.8 ± 2.4 | 27.5 | 94 |
M5 | 471.7 ± 34.6 | 21.3 ± 1.0 | 45.2 | 43 |
M6 | 143.5 ± 5.5 | 31.5 ± 0.8 | 219.7 | 64 |